Anas Al-Janadi

420 total citations
25 papers, 309 citations indexed

About

Anas Al-Janadi is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Anas Al-Janadi has authored 25 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Anas Al-Janadi's work include Cancer Immunotherapy and Biomarkers (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Prostate Cancer Treatment and Research (3 papers). Anas Al-Janadi is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Prostate Cancer Treatment and Research (3 papers). Anas Al-Janadi collaborates with scholars based in United States, Czechia and Canada. Anas Al-Janadi's co-authors include Peter C. Kurniali, Borys Hrinczenko, Sreenivasa R Chandana, Barbara A. Conley, Krishnan Ganapathy, Eric A. Singer, Arkadiusz Z. Dudek, Joshua M. Lang, Heather Laird‐Fick and Ajjai Alva and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Anas Al-Janadi

23 papers receiving 306 citations

Peers

Anas Al-Janadi
Comparison fields: 5 of 57
  • Oncology 182
  • Pulmonary and Respiratory Medicine 91
  • Molecular Biology 86
  • Pathology and Forensic Medicine 68
  • Cancer Research 45
Replace Paule Augereau with:
Paule Augereau France
Kelsey Klute United States
Joan B. Heijns Netherlands
Laura Demurtas Italy
Minghan Jia China
Charuwan Akewanlop Thailand
Jan Pander Netherlands
Wei‐Shu Wang Taiwan
Jesper Andreas Palshof Denmark
Giulia Grizzi Italy
Paule Augereau France View profile →
Citations per field, relative to Anas Al-Janadi
Anas Al-Janadi · 1×
Citations per year, relative to Anas Al-Janadi
Anas Al-Janadi · 1×

Countries citing papers authored by Anas Al-Janadi

Since Specialization
Citations

This map shows the geographic impact of Anas Al-Janadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anas Al-Janadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anas Al-Janadi more than expected).

Fields of papers citing papers by Anas Al-Janadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anas Al-Janadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anas Al-Janadi. The network helps show where Anas Al-Janadi may publish in the future.

Co-authorship network of co-authors of Anas Al-Janadi

This figure shows the co-authorship network connecting the top 25 collaborators of Anas Al-Janadi. A scholar is included among the top collaborators of Anas Al-Janadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anas Al-Janadi. Anas Al-Janadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 1
2 5
3 33
4 10
5 16
6 0
7 2
8 121
9 1
10 1
11 1
12 2
13 1
14 3
15 10
16 2
17
Endothelins as a Potential Target for Anticancer Therapy
1
18 36
19
BCNU toxicity presenting with a large pericardial and pleural effusion.
9
20 33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026